EMSL Buys a VITEK@MS MALDI TOF for Rapid Pathogen Identification
EMSL Analytical, Inc. has purchased a bioMerieux VITEK@MS MALDI TOF (Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectroscopy). The technology uses charged molecular signatures for rapid identification of pathogens. It is particularly useful for the identification of pathogenic bacteria, molds and yeasts using a library of over 25,000 spectra for clinically relevant micro-organisms.
“Identification can be accomplished in a matter of minutes after culturing the organisms,” said Diane Miskowski, MPH, Business Development Manager of EMSL Analytical, Inc. “This technology provides exceptional speed and accuracy over traditional biochemical and gas chromatographic identification techniques and is well suited to high-throughput laboratories.”
EMSL is currently validating the equipment for the identification of pathogens in pharmaceutical products.
Tags: Identification, MALDI-TOF
Date Published: March 3, 2014
Source article link: EMSL » company contact details
12th Annual PDA Global Conference on Pharmaceutical Microbiology
Hygiena Expands Testing Portfolio to Cover Entire Contamination Detection Spectrum
Bruker Acquires MERLIN Adding Speciality AST and ART
IDbyDNA and ARUP Laboratories to Develop NGS Tests
FDA Clears Identification of Mycobacteria, Nocardia and Moulds on VITEK® MS